Ketek is an antibiotic manufactured by Sanofi-Avenis. It was approved in 2004 for treatment of acute bacterial infections from chronic bronchitis, acute bacterial sinusitis and community-acquired pneumonia. On January 20, 2006, researchers three cases of severe liver problems, including one death were reported after they began taking the antibiotic Ketek (Generic: Telithromycin). Federal regulators are investigating.

.On May 19, 2006 the FDA linked 12 cases of liver failure, which include four deaths to the antibiotic Ketek. The FDA is now urging Sanofi-Aventis, the manufacturer of Ketek to add a warning label to the drug. Ketek was refused approval by the FDA back in 2001 and 2003 due to the lack safety information on the drugs label.

If you or someone you know took Ketek and suffered liver problems or other severe injury, contact us for a free case evaluation.